Navigation Links
Federal NuvaRing Blood-Clotting Lawsuits Report: Resource4thePeople Updates Consumers with News That First Bellwether Trial Rescheduled to July
Date:3/2/2013

San Diego CA (PRWEB) March 02, 2013

In its latest update to consumers about the progress of more than 1,000 lawsuits involving claims that the NuvaRing contraceptive puts women at higher risk of blood clotting, Resource4thePeople is reporting today that the first bellwether trial in the litigation* has been rescheduled to July. http://www.resource4thepeople.com/defectivedrugs/nuvaring.html

"In continuing to update consumers about these important cases, which may have ramifications for the millions of women who chose the NuvaRing as their method of contraception, we have to report that the first bellwether, or test trial, in the litigation will not be as early as first anticipated," said Resource4thePeople.

"This trial has been rescheduled several times but Judge Rodney Sippel has now put on the record that in his view July is the best month in order to accommodate the needs of both plaintiffs and defendants.

"We will continue to monitor the progress of this litigation and provide the latest news for the increasing number of women who have been contacting us for information about this important litigation."

Resource4thePeople announced that it will continue to provide lawyers offering free consultations to women who may have suffered severe health problems as a result of their use of the NuvaRing intrauterine device.

"The question we have frequently been receiving is whether it is too late to file a lawsuit as this litigation before Judge Sippel proceeds," said Resource4thePeople. "The answer, in most cases, is no."

For instance, said Resource4thePeople, one of the most recent such NuvaRing lawsuits** was filed last week by a Philadelphia woman who claims she suffered a venous sinus thrombosis and an intracranial hemorrhage last year.

In her lawsuit, the woman is claiming that those problems were caused by blood clotting caused by her use of a NuvaRing IUD over seven years.

In her court filing, the woman said she has been forced to undergo a daily Coumadin regimen for her health problems, and suffers from depression and social anxiety.

Named as defendants are Organon Pharmaceuticals USA Inc., Organon International Inc. and Schering-Plough Corp., who, according to the court file, allegedly falsely marketed and sold the NuvaRing as a safe, efficient alternative to birth control pills.

As with the NuvaRing lawsuits in the multidistrict litigation, the Philadelphia woman claims that the defendants were negligent in not fully informing the public and health care professionals about increased risk of blood-clotting from the use of the contraceptive, according to the court filing.

The allegations cited in the multidistrict litigation claim that the NuvaRing, described by company officials as the first hormonal IUD, puts women at risk of suffering blood clots that can lead to life-threatening health problems because of the hormone mixture that prevents pregnancies.

The NuvaRing was approved by the Food and Drug Administration in 2001 after being created by Organon as a flexible IUD, or ring, hence the name. The IUD releases a low dose of etonogestrel and estrogen over three weeks, providing women the flexibility of a monthly contraceptive.

This flexibility was one of the marketing factors that made the NuvaRing what was described as an easy and healthy contraceptive choice to women who were not satisfied with the side effects caused by birth control pills and the necessity of taking them each day.

However, by 2011 the FDA released the findings of government research that put women who used the NuvaRing or other IUDs with a similar mixture of hormones at a 56 percent higher risk of suffering blood clotting that led to deep vein thrombosis and pulmonary embolisms than women on birth control pills.***

Resource4thePeople is committed to informing women about the risks they may face in their choices of contraception and providing them data that ensures the protection of their health and that of any infants they may give birth to who may be exposed to side effects from contraceptive devices.

In announcing that free legal consultations are still being offered to women who may have suffered serious side effects from the use of the NuvaRing, Resource4thePeople notes that NuvaRing has now posted warnings about the increased risks of suffering blood clots on the company’s web site under the heading of “IMPORTANT SAFETY INFORMATION.****

"Our legal consultations can spell out the options available to women who may have suffered health problems from blood clotting, such as deep vein thrombosis, pulmonary embolisms, strokes and heart attacks," said Resource4thePeople.

Legal assistance also is available to those who may have lost a loved one and may be seeking information about the facts involved in a wrongful death.

“This announcement is being made in case there is any confusion among women who might have suffered serious health problems similar to those alleged in what is now a large, consolidated federal court proceeding,” said Resource4thePeople.

Multidistrict litigations are designated by a special panel of federal judges in cases in which large numbers of plaintiffs file similar allegations against common defendants in the interest of judicial efficiency and to avoid duplicative and conflicting legal proceedings.

In such litigations the judge oversees pre-trial evidence-gathering and legal requirements, schedules bellwether cases to allow both plaintiffs and defendants to weigh the strengths and weaknesses of their cases and presides over mediations and settlement discussions.

The judge is also asked to rule on whether such cases should be certified as class-action cases, in which a large pool of plaintiffs are given the choice of whether to remain in the litigation or proceed with their individual case outside of the outcome of the class action.

Sources:

  • In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, U.S. District Court, Eastern District of Missouri
** Case No. 2:13cv0099, U.S. District Court for the Eastern District of Pennsylvania
***http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
**** http://www.nuvaring.com/Consumer/index.asp

Read the full story at http://www.prweb.com/releases/2013/3/prweb10484983.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Wright Hip Implant Lawyers at Bernstein Liebhard LLP Note Scheduling of Next Status Conference in Federal Wright Conserve Hip Replacement Litigation
2. Massachusetts' Deval Patrick Wins "Green Governor of the Year Award" -- First State to Win Federal Approval for Offshore Wind Farms says BE
3. Securityhunter Hires DigitalFury Technologies to Furnish Program Management Support for Federal Electronic Security System Programs
4. The ethics of access: Comparing 2 federal health care reform efforts
5. Federal Way Retirement Community to Host Event on Senior Living Options and Special Programs
6. Michigan Criminal Attorney, Loren Dickstein, Successfully Assists Client with Avoiding Serving Time in Federal Prison
7. North Shore-LIJ awarded $300,000 federal grant for prostate cancer research training
8. Pradaxa Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
9. DePuy ASR Hip Recall: Status Conference Held in Federal DePuy ASR Hip Litigation in Ohio
10. DePuy Pinnacle Lawsuits: Explant Preservation Order Issued in Federal DePuy Pinnacle Hip Litigation
11. Actos Bladder Cancer Lawsuits: Next Status Conference in Federal Actos Litigation Scheduled for January 24, 2013, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... flexibility in repaying their loans, more information about their loan terms and accounts, ... outstanding student loan debt, including federal and private loans, has reached $1.3 trillion, ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  The blood testing market ... dollars, according to Kalorama Information and The Freedonia Group ... and nucleic acid testing.  The healthcare research firm said ... in developing blood collection stations and in improving testing ... Kalorama Information,s report, Blood Testing Market in ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
Breaking Medicine Technology: